Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation.
Yuri YagamiHideyuki NiwaHideaki ManabeHiroki YamamotoSakiko OtaniTakashi SatoSatoshi IgawaMasaru KubotaJiichiro SasakiKatsuhiko NaokiPublished in: OncoTargets and therapy (2022)
This case highlights the importance of assessing genetic alterations in lung cancer patients with peritoneal carcinomatosis and treating them with appropriate molecular targeted drugs.